Pharmacology
News
PPIs linked to long-term infection in kids
Experts said the new data show the importance of limiting use of this type of acid suppressant in children.
Article
Mepolizumab improves asthma after 1 year despite comorbidities
Patients with asthma and comorbid chronic rhinosinusitis with nasal polyps showed especially significant benefits.
News
Ruxolitinib for vitiligo: Experts share experiences from first year
Many patients “don’t hit their optimal results at 3 months, 6 months, even the year mark. With continued use, many can see continued benefit,”...
News
Diabetes drug class appears to reduce recurrent gout flares
Previously associated with a lower incidence of gout, SGLT2 inhibitors for the first time also appear to reduce gout flare recurrence and excess...
Latest News
How to optimize in-hospital antimicrobial prescribing?
Variability in antimicrobial prescribing among hospital-based physicians is not associated with patient characteristics or clinical outcomes, data...
Conference Coverage
Probiotics improve nonmotor symptoms of Parkinson’s
Participants taking the probiotic also saw a reduced delay in “time to on” of treatment with levodopa, thus reducing the delay until effectiveness...
News
Delaying palliative chemo may improve QoL without affecting survival for asymptomatic patients
For asymptomatic patients, delaying the start of systemic therapy should be discussed with the patient.
News
Hemophilia: Concizumab lessens bleeding, could expand treatment options
The subcutaneous drug concizumab could be an important first treatment for hemophilia B with inhibitors; FDA resubmission is planned.
News
FDA approves canakinumab for gout flares
Canakinumab is the first biologic in the U.S. approved for treating gout flares.
Conference Coverage
Dietary nitrates reduce contrast-induced nephropathy in ACS
“Currently, aside from intravenous hydration, there is no proven treatment that reduces contrast-induced nephropathy. We feel that dietary...